Edward Naureckas is a Respiratory physician affiliated with University of Chicago. OpenAlex indexes 128 publications with 4,972 citations (h-index 35).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5841 S Maryland Ave
Chicago, IL 606371443
Telephone
888-824-0200Provider last certified this registry record 25 Sept 2025.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
81.4%Corticosteroid30.5%Trelegy Ellipta36%Breo Ellipta19%Fluticasone Propionate11%Symbicort9%Dulera7%Fluticasone Propionate Hfa6%Pulmicort Flexhaler5%Arnuity Ellipta4%Budesonide-Formoterol Fumarate4%Part D<11 patientsbeta2-Adrenergic Agonist19.5%Albuterol Sulfate Hfa70%Ventolin Hfa30%Part D≥51 patients+ 6 more classes in this area
Metabolism & gastrointestinal
8.5%Corticosteroid4.5%Prednisone100%Part D≥27 patientsAntidiarrheal microorganisms4%Zenpep71%Creon29%Part D<11 patientsDermatology
3.8%Interleukin-4 Receptor alpha Antagonist3.8%Dupixent Pen63%Dupixent Syringe38%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1992–2010 per NIH RePORTER. The latest:
- CONCERT-Clinical Effectiveness Research (CONCERT-CER)
University of Chicago
FY2010$3,537,987RC2HL101618
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients
American Journal of Respiratory and Critical Care Medicine
2024 - Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations
International Forum of Allergy & Rhinology
2022 - DNA methylation signatures in airway cells from adult children of asthmatic mothers reflect subtypes of severe asthma
Proceedings of the National Academy of Sciences
2022 - The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions
Journal of Allergy and Clinical Immunology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
Ralph Weichselbaum, MD
University of Chicago
Mary Rinella, MD
University of Chicago
Hedy Kindler, MD
University of Chicago
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”